Altering AAV tropism with mosaic viral capsids (Q52048598)

20 April 2018

title

Altering AAV tropism with mosaic viral capsids (English)

1 reference

20 April 2018

Thomas Weber

7

0 references

author name string

Laure Gigout

1

1 reference

20 April 2018

Patricia Rebollo

2

1 reference

20 April 2018

Nathalie Clement

3

1 reference

20 April 2018

Kenneth H Warrington

4

1 reference

20 April 2018

Nicholas Muzyczka

5

1 reference

20 April 2018

R Michael Linden

6

1 reference

20 April 2018

publication date

1 June 2005

1 reference

20 April 2018

published in

Molecular Therapy

1 reference

20 April 2018

volume

11

1 reference

20 April 2018

issue

6

1 reference

20 April 2018

page(s)

856-865

1 reference

20 April 2018

Transfer of Contaminants in Adeno-Associated Virus Vector Stocks Can Mimic Transduction and Lead to Artifactual Results

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Cell lines for the production of recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Clades of Adeno-associated viruses are widely disseminated in human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Novel tools for production and purification of recombinant adenoassociated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Generation and characterization of chimeric recombinant AAV vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Building a better vector: the manipulation of AAV virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Structural mimicry of a native protein by a minimized binding domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

Characterization of adenovirus-associated virus-induced polypeptides in KB cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

1 reference

https://api.crossref.org/works/10.1016/J.YMTHE.2005.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2005.03.005

1 reference

20 April 2018

1 reference

20 April 2018